We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PEP:PYTHPEPSICO INC / US DOLLAR Analysis

Data as of 2026-03-15 - not real-time

$159.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

PepsiCo’s stock is trading at $159.88, comfortably above its 50‑day (164.18) and 200‑day (146.05) simple moving averages, indicating a bullish trend despite a recent dip below the 20‑day SMA. The RSI sits at 46, suggesting neutral momentum, while the MACD histogram remains negative, hinting at short‑term bearish pressure and a decreasing volume trend. Valuation metrics are mixed: a forward P/E of 17.5 and a solid 5.6% revenue growth point to growth potential, yet the DCF‑derived fair value of $72.24 signals a substantial overvaluation of the current price. The dividend yield of 3.56% is attractive, but a 93.7% payout ratio raises sustainability concerns given the company’s high debt‑to‑equity of 258%. Recent news shows the stock up 18% YTD, Barclays lifting its price target to $160, and the share price hitting a 52‑week high of $170.81, reinforcing positive sentiment (Fear & Greed Index at 72 – “Greed”). Analyst consensus remains a “hold” with a median target of $173, reflecting confidence in the brand but caution on valuation. Overall, the stock presents a blend of growth and value attributes, with strong cash flow offset by leverage and dividend‑paying pressures.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at $156
  • Bearish MACD histogram
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong cash flow and dividend yield
  • Revenue growth and solid operating margins
  • Technical bullish bias above SMA50/200

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Brand moat and global distribution network
  • High leverage and near‑full payout ratio
  • Significant gap between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin8.77%
P/E Ratio26.6
ROE42.85%
ROA9.05%
Debt/Equity258.08
P/B Ratio10.7
Op. Cash Flow$12.1B
Free Cash Flow$8.2B

Technical Analysis

TrendBullish
RSI46.2
Support$156.09
Resistance$170.28
MA 20$164.18
MA 50$156.18
MA 200$146.05
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$72.24
Target Price$171.24
Upside/Downside7.10%
GradeOvervalued
TypeBlend
Dividend Yield3.56%

Risk Assessment

Beta0.18
Volatility26.06%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.